-
Pharma leaders, policy makers discuss COVID-19 impact, way forward for industry
expresspharma
June 02, 2020
Most are optimistic about the future but accentuate the need for investments in technology and other strategic measures to ensure progress.
-
Government launches coronavirus test and trace service
pharmatimes
June 01, 2020
The UK government has today launched its NHS Test and Trace service in a bid to identify, contain and control coronavirus to reduce its spread and save lives.
-
CRUK, Latus and Edinburgh Uni launch test camostat for COVID-19
pharmatimes
June 01, 2020
Cancer Research UK and its partners have kicked off a clinical trial to determine the potential of repurposing a drug used to treat inflammation of the pancreas for the treatment of COVID-19.
-
Roche initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patien
worldpharmanews
June 01, 2020
Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA) to evaluate the safety and efficacy of Actemra/RoActemra plus the investigational antiviral remdesivir ...
-
Glucocorticoids are harmful in treating viral respiratory infections
worldpharmanews
June 01, 2020
Glucocorticoids are widely used in treating acute respiratory distress syndrome (ARDS) despite there being no indisputable scientific evidence of their effectiveness.
-
FDA Lists Beckman Coulter RNA Extraction Kit for Use in EUA-Authorized COVID-19 Test
americanpharmaceuticalreview
June 01, 2020
Beckman Coulter Life Sciences announced RNAdvance Viral XP has been added to the list of acceptable extraction methods for use in the Centers for Disease Control's EUA-authorized COVID-19 test referenced in the FDA's FAQ on testing for SARS-CoV-2.
-
Novartis’ AveXis agrees to manufacture US researcher Covid-19 vaccine
pharmaceutical-technology
June 01, 2020
Novartis unit AveXis has entered a manufacturing agreement with researchers at Massachusetts Eye and Ear and Massachusetts General Hospital in the US to produce a genetic vaccine against Covid-19, AAVCOVID.
-
Pfizer ties up with glass maker Corning for vial supply
expresspharma
June 01, 2020
Pfizer, like rivals Merck & Co and AstraZeneca, is racing to develop a vaccine for COVID-19, the illness caused by the novel coronavirus, which does not yet have an approved vaccine or treatment.
-
EU plans permanent stockpile of essential drugs, medical gear
expresspharma
June 01, 2020
The stockpile would be funded from a new health budget worth 9.4 billion euros ($10.3 billion) which the EU executive commission proposed.
-
Sun Pharma gets DCGI nod for clinical trial with Nafamostat in COVID-19 patients
expresspharma
June 01, 2020
Nafamostat is identified as a potential candidate for COVID-19 patients by scientists at the University of Tokyo and Leibniz Institute for Primate Research, Germany.